Modified Vaccinia Ankara
Showing 1 - 25 of 5,155
Cytomegaloviral Infection, Hematopoietic Cell Transplant Recipient Trial in Duarte (Laboratory Biomarker Analysis, Multi-peptide
Recruiting
- Cytomegaloviral Infection
- Hematopoietic Cell Transplant Recipient
- Laboratory Biomarker Analysis
- Multi-peptide CMV-Modified Vaccinia Ankara Vaccine
-
Duarte, CaliforniaCity of Hope Medical Center
Jun 14, 2022
Accelerated Phase Chronic Myelogenous Leukemia, BCR-ABL1 Positive, Acute Lymphoblastic Leukemia, Acute Myeloid Leukemia Trial in
Active, not recruiting
- Accelerated Phase Chronic Myelogenous Leukemia, BCR-ABL1 Positive
- +11 more
- Letermovir
- +2 more
-
Duarte, CaliforniaCity of Hope Medical Center
Dec 8, 2022
Acute Lymphoblastic Leukemia, Acute Myeloid Leukemia, Chronic Lymphocytic Leukemia Trial in Duarte, Atlanta (procedure, drug,
Not yet recruiting
- Acute Lymphoblastic Leukemia
- +9 more
- Allogeneic Hematopoietic Stem Cell Transplantation
- +7 more
-
Duarte, California
- +1 more
Sep 22, 2023
High Grade B-Cell Non-Hodgkin's Lymphoma, Intermediate Grade B-Cell Non-Hodgkin's Lymphoma, Recurrent B-Cell Non-Hodgkin
Not yet recruiting
- High Grade B-Cell Non-Hodgkin's Lymphoma
- +3 more
- Anti-CD19-CAR CMV-specific T-lymphocytes
- +9 more
-
Duarte, CaliforniaCity of Hope Medical Center
Apr 5, 2023
Cytomegalovirus Infections, HIV, Vaccine Trial in United States (CMV-MVA Triplex, Placebo)
Recruiting
- Cytomegalovirus Infections
- +2 more
- CMV-MVA Triplex
- Placebo
-
Birmingham, Alabama
- +11 more
Jun 20, 2022
Lynch Syndrome Trial in Puerto Rico, United States (Adenoviral Tumor-specific Neoantigen Priming Vaccine GAd-209-FSP, MVA
Recruiting
- Lynch Syndrome
- Adenoviral Tumor-specific Neoantigen Priming Vaccine GAd-209-FSP
- +2 more
-
Duarte, California
- +3 more
Nov 22, 2022
Human Immunodeficiency Virus Trial in Bangkok (Ad26.Mos.HIV, MVA-Mosaic, Placebo)
Completed
- Human Immunodeficiency Virus
- Ad26.Mos.HIV
- +2 more
-
Bangkok, Thailand(unnamed)
Dec 29, 2021
Monkeypox Virus Infection Trial in Boende (IMVAMUNE)
Active, not recruiting
- Monkeypox Virus Infection
- IMVAMUNE
-
Boende, Tshuapa, Congo, The Democratic Republic of theTshuapa site
May 11, 2022
Metastatic Colorectal Cancer Trial in United States (mFOLFOX6, MVA-BN-CV301, FPV-CV301)
Active, not recruiting
- Metastatic Colorectal Cancer
- mFOLFOX6
- +3 more
-
Duarte, California
- +6 more
Jan 18, 2023
Lung Cancer, Breast Cancer, Prostate Cancer Trial run by the NCI (MVA-brachyury- TRICOM)
Completed
- Lung Cancer
- +4 more
- MVA-brachyury- TRICOM
-
Bethesda, MarylandNational Institutes of Health Clinical Center, 9000 Rockville Pi
Jan 11, 2021
B-Cell Non-Hodgkin Lymphoma, DLBCL, Mantle Cell Lymphoma Trial in Duarte (Anti-CD19-CAR CMV-specific T-lymphocytes, Autologous
Not yet recruiting
- B-Cell Non-Hodgkin Lymphoma
- +7 more
- Anti-CD19-CAR CMV-specific T-lymphocytes
- +3 more
-
Duarte, CaliforniaCity of Hope Medical Center
Jun 28, 2022
Human Immunodeficiency Virus Trial in Boston (Ad26.Mos4.HIV, MVA-Mosaic, Clade C gp140 + Mosaic gp140)
Completed
- Human Immunodeficiency Virus
- Ad26.Mos4.HIV
- +3 more
-
Boston, MassachusettsBeth Israel Deaconess Medical Center
Feb 7, 2022
Accelerated Phase Chronic Myelogenous Leukemia, BCR-ABL1 Positive, Acute Lymphoblastic Leukemia in Remission, Acute Myeloid
Active, not recruiting
- Accelerated Phase Chronic Myelogenous Leukemia, BCR-ABL1 Positive
- +12 more
- Laboratory Biomarker Analysis
- +2 more
-
Duarte, California
- +2 more
Feb 17, 2022
HPV Infection, CIN1 Trial in Belgium, Estonia, United Kingdom (ChAdOx1-HPV, MVA-HPV, Placebo)
Active, not recruiting
- HPV Infection
- CIN1
- ChAdOx1-HPV
- +2 more
-
Antwerp, Belgium
- +15 more
Jan 9, 2023
NSCLC (NSCLC) Trial in United Kingdom (ChAdOx1-MAGEA3-NYESO, MVA-MAGEA3, Standard of care treatment)
Recruiting
- Non-small Cell Lung Cancer (NSCLC)
- ChAdOx1-MAGEA3-NYESO
- +2 more
-
Birmingham, United Kingdom
- +7 more
Dec 16, 2021
Ebola Disease, Immunisation Trial in Cincinnati (ChAd3-EBO-Z, MVA Multi-Filo Ebola Vaccine, Placebo)
Completed
- Ebola Disease
- Immunisation
- ChAd3-EBO-Z
- +2 more
-
Cincinnati, OhioCincinnati Children's Hospital Medical Center - Infectious Disea
May 6, 2021
Recurrent Non-Small Cell Lung Carcinoma, Stage I NSCLC, Stage II NSCLC Trial in United States (TG4010, Nivolumab)
Completed
- Recurrent Non-Small Cell Lung Carcinoma
- +5 more
- TG4010
- Nivolumab
-
Duarte, California
- +3 more
Oct 11, 2021
Human Papillomavirus Infections Trial in Belgium, United States (Ad26.HPV16, Ad26.HPV18, MVA.HPV16/18)
Terminated
- Human Papillomavirus Infections
- Ad26.HPV16
- +3 more
-
Doral, Florida
- +11 more
Nov 23, 2021
Non-melanoma Skin Cancer, Basal Cell Carcinoma, Squamous Cell Carcinoma Trial in Montréal (Imvamune)
Recruiting
- Non-melanoma Skin Cancer
- +2 more
- Imvamune
-
Montréal, Quebec, CanadaMcGill University Health Centre
Nov 26, 2020
Safety Issues Trial run by the (MVA-BN-Brachyury/ FPV-Brachyury)
Completed
- Safety Issues
- MVA-BN-Brachyury/ FPV-Brachyury
-
Bethesda, MarylandGenitourinary Malignancies Branch National Cancer Institute
Aug 25, 2020
Adult Solid Tumor, Bladder Carcinoma, Colon Carcinoma Trial in Duarte (Laboratory Biomarker Analysis, Modified Vaccinia Virus
Active, not recruiting
- Adult Solid Neoplasm
- +16 more
- Laboratory Biomarker Analysis
- +2 more
-
Duarte, CaliforniaCity of Hope Medical Center
Mar 17, 2022
Cutaneous Squamous Cell Carcinoma, SCC - Squamous Cell Carcinoma, Basal Cell Carcinoma Trial in United States (MQ719,
Recruiting
- Cutaneous Squamous Cell Carcinoma
- +18 more
- MQ719
- Pembrolizumab
-
Basking Ridge, New Jersey
- +6 more
May 18, 2023
Liver Transplant Trial in United States (CMV-MVA Triplex, Placebo for CMV-MVA Triplex)
Not yet recruiting
- Liver Transplant
- CMV-MVA Triplex
- Placebo for CMV-MVA Triplex
-
Redwood City, California
- +16 more
Oct 10, 2023
Lung Cancer Trial in New York (GL-ONC1)
Active, not recruiting
- Lung Cancer
- GL-ONC1
-
New York, New YorkMemorial Sloan Kettering Cancer Center
Feb 7, 2022
Monkeypox Trial in United States (JYNNEOS)
Not yet recruiting
- Monkeypox
- JYNNEOS
-
San Diego, California
- +7 more
Aug 20, 2022